Plasma p-tau217, quantified by the fully automated LUMIPULSE G platform, outperforms p-tau181 in predicting amyloid pathology in cognitive complaints patients.

ABSTRACT:

SUBMITTER: Silva-Spinola A 

PROVIDER: S-EPMC12858865 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature